A 68-year-old woman with Felty's syndrome was admitted to our hospital due to breathlessness. She was diagnosed as having rheumatoid arthritis at age 59 years. 
Introduction
AIH is a chronic necroinflammatory hepatic disorder of unknown etiology, although it is thought to be caused by immune dysregulation (1, 2) , and is a disease characterized by hypergammaglobulinemia, increased titer of autoantibodies and chronic hepatitis with piecemeal necrosis and infiltration of plasma cells into the portal tracts. AIH is often associated with a number of autoimmune diseases, such as Sjögren's syndrome and immune thrombocytopenia (3, 4) . However, AIH involvement in patients with Felty's syndrome is generally considered very rare.
In this report, we present a patient suffering from Felty's syndrome concomitant with chronic hepatitis that is apparently compatible with AIH.
Case Report
A 68-year-old woman was admitted to our hospital with general fatigue, palpitation, shortness of breath and leg edema. She was diagnosed as having rheumatoid arthritis (RA) at age 59 years at another hospital. She had since been treated with nonsteroidal anti-inflammatory drugs, gold sodium thiomalate and steroids. When she consulted our hospital, clinical classification was stage IV and class II, due to the bilateral erosive arthritis in her hands, wrists, knees and feet.
In 1996 (at age 62 years), pancytopenia, which might have been induced by gold sodium thiomalate, gradually developed. This medication was discontinued, but the pancytopenia persisted. Over the subsequent year, findings on gastrointestinal endoscopy and abdominal computed tomography revealed contracted liver, splenomegaly and esophageal varices. Laboratory data showed no antigens or antibodies for hepatitis virus, or antibodies for mitochondria or smooth muscle, with the exception of antinuclear antibody (ANA). Esophageal variceal banding ligature was thus performed.
Physical examination demonstrated deformities of the bilateral joint of the hands, wrists, and feet. Swan-neck, boutonniere deformity and radial deviation at the wrists with ulnar deviation of the digits were noted in both hands. Respiratory and heart sounds were normal. The spleen was palpable about 5 cm below the left costal margin. Slight pitting edema was observed in the bilateral lower extremities.
Laboratory findings are shown in Table 1 . Urinalysis was within the normal range. Neutropenia and hypoproteinemia worsened, and hypoalbuminemia at 2.0 g/dl was detected. Elevated levels of total bilirubin and aspartate aminotransferase were observed, and the Child-Pugh classification was C (10 points). ANA was positive at a titer of 640 (homogenous and speckled), but other antibodies were negative. Abdominal computed tomography revealed contracted liver, splenomegaly, ascites (Fig. 1A) and enlarged serpiginous splenic vein (Fig. 1B) .
During admission, oral prednisolone was discontinued due to various infections, including bacterial pneumonia and methicillin resistant Staphylococcus aureus (MRSA) colitis. Subcutaneous administration of granulocyte colony stimulating factor (three times a week) was thus performed, while ascites was simultaneously treated with diuretics. Laparoscopic liver biopsy was not performed due to marked ascites and neutropenia. Liver dysfunction worsened gradually and ascites became prominent (Fig. 2) revealed hepatic failure, elevated transaminases, ammonia and total bilirubin and decreased cholinesterase, albumin, prothrombin time and total cholesterol ( Table 2) . She developed hepatic encephalopathy and died from hepatic failure and emaciation on March 31, 2003. Autopsy was not permitted. Needle autopsy of the liver confirmed chronic hepatitis, the lobular architectures were maintained, while part of the portal field exhibited fibrosis including piecemeal necrosis, and was invaded by inflammatory cells and numerous lymphocytes with plasma cells (Fig. 3A, 3B ). Pathological findings were consistent with a diagnosis of chronic hepatitis, which appeared to be AIH, although inflammatory cell invasion was not severe. According to the criteria of the International Autoimmune Hepatitis Group (Table 3A , 3B), the patient scored 19 points based on laboratory findings, pathophysiological consequences and clinical course, and her condition was diagnosed as AIH.
Discussion
In 1924, Felty first called attention to five cases with a triad of RA, splenomegaly and neutropenia (5) . This combination of disorders was designated Felty's syndrome in a subsequent report by Hanrahan and Miller (6) . liver involvement, while common hepatic abnormalities are nodular regenerative hyperplasia, abnormal lobular architecture, portal fibrosis and cirrhosis (7-11). Thorne et al reported a tendency for patients with abnormal liver findings to have a higher incidence of vasculopathy and Felty's syndrome patients should be screened for portal hypertension as they have an increased likelihood of bleeding from esophageal varices (9) . Indeed, in this patient, esophageal varices were observed. The most common liver involvement in patients with Felty's syndrome is nodular regenerative hyperplasia (12, 13). Goritsas et al recommended that signs of portal hypertension and/or intrahepatic cholestasis in RA patients should alert the physician to the possibility of nodular regenerative hyperplasia, even in the absence of Felty's syndrome (14) . However, the cause of hepatic nodular regenerative hyperplasia in patients with Felty's syndrome remains unresolved.
In the present case, contracted liver was thought to be clinically liver cirrhosis based on blood test, abdominal computed tomography and ultrasonography findings. However, liver autopsy findings revealed chronic hepatitis. Histological findings showed a basically normal architecture and a partly piecemeal necrosis in the portal triad field, in addition to infiltration of lymphocytes with plasma cells, which suggested AIH. AIH was first reported by Mackay et al in 1965. The characteristic pathologic features were chronic active hepatitis with piecemeal necrosis, lobular involvement, and bridging necrosis with lymphocytes and plasma cells (15) . The clinical features were similar to chronic viral hepatitis. For diagnosis of AIH, it was recently recommended to use the scoring system of the International Autoimmune Hepatitis Group (16) . According this scoring system, the present patient was diagnosed as having autoimmune hepatitis with a score 19 points. Kaise et al reported that one in 49 patients with Felty's syndrome exhibits concomitant AIH (11) . Based on that report, it is certain that AIH in Felty's syndrome is extremely rare.
Splenomegaly in patients with Felty's syndrome might be due to expansion of the sinusoidal pulp, as indicated by wider separation of the periarterial lymphoid sheaths and hyperplastic germinal center (17) . In the present case, we are convinced that increasing blood flow to the spleen due to splenomegaly caused portal hypertension, congestion of blood within the liver, and chronic hepatitis gradually worsened to liver failure.
The present patient had contracted liver disease of unknown etiology. Chronic hepatitis compatible with AIH was diagnosed based on an international scoring system and the pathological findings of needle autopsy respectively. In patients with Felty's syndrome, severe hepatitis is rarely observed and correlations with the liver are difficult to confirm. When treating Felty's syndrome patients with severe liver dysfunction, AIH should be considered. Inaba et al reported a case in which the patient had been treated by prednisolone for AIH and was diagnosed as having Felty's syndrome (18) . This report raises the possibility that our patient had AIH when she was diagnosed with RA and prednisolone therapy suppressed the clinical features of AIH. Retracing the clinical course, liver dysfunction may have developed after steroid therapy was discontinued. If this was the case scenario, the response to therapy in this patient should, in fact, be considered as a relapse with a score of 21 points. In the present patient, the most difficult point was that steroid therapy had to be discontinued due to life threatening infections (MRSA colitis, recurrent pneumonia) which might have been due to 
